The originating document has been archived. We cannot confirm the completeness, accuracy, or currency of the content.

Phenylpropanolamine 50 mg

This page contains information on Phenylpropanolamine 50 mg for veterinary use.
The information provided typically includes the following:

Phenylpropanolamine 50 mg Indications
Warnings and cautions for Phenylpropanolamine 50 mg
Direction and dosage information for Phenylpropanolamine 50 mg

Phenylpropanolamine 50 Mg

This treatment applies to the following species:

Dogs

Manufacturer: VetOne

(phenylpropanolamine Hydrochloride)

50 Mg Chewable Tablets

for Use In Dogs Only

caution

Federal law restricts this drug to use by or on the order of a licensed veterinarian.

DESCRIPTION

PPA chewable tablets contain 50 mg of phenylpropanolamine hydrochloride. Phenylpropanolamine is an α-adrenergic agonist which has been shown to increase urethral sphincter pressure in dogs. Loss of urethral sphincter tone and decreased sphincter pressure is associated with urinary incontinence in ovariohysterectomized or anestrous dogs.

Phenylpropanolamine 50 mg Indications

PPA is indicated for the control of urinary incontinence caused by urethral sphincter incompetence in female dogs.

Dosage & Administration

The recommended dose of PPA is 3 mg per kg body weight per day, divided into two or three equal oral doses. Some patients may achieve an adequate clinical response with a lower dose. Dosage may be rounded to the nearest 12.5 mg for practical dosing.

Warnings

Not for human use. Keep this and all drugs out of reach of children. PPA should be avoided or used cautiously in dogs with glaucoma, cardiac disease, hypertension, renal insufficiency, and diabetes mellitus.

Precautions

PPA should not be administered with other sympathomimetic drugs or tricyclic antidepressants, nor within two weeks of a monoamine oxidase inhibitor because of the risk of acute hypertension. PPA may increase the risk of cardiac arrhythmias from halogenated gaseous anesthetics. Possible side effects include restlessness, irritability, tachycardia, hypertension, and anorexia. It may take several days for the full benefit of the drug to be seen. Missed doses may negate the desired effect.

Adverse Reactions

Adverse reactions related to administration of PPA may include restlessness, irritability, tachycardia, hypertension, urinary retention and anorexia.

Storage

Store between 2°-30°C (36°-86°F). Keep container tightly closed.

For use in animals only.

Distributed by: MWI, Meridian, ID 83680

(888) 694-8381

MADE IN USA

Net Contents:	NDC:
60 Tablets	13985-048-63	V1 503049

Nac No.

13150650

VET ONE
Distributed by MWI Veterinary Supply
651 S. STRATFORD DRIVE, SUITE 100, MERIDIAN, ID, 83642

Customer Service:		888-694-8381
Toll-Free:		800-824-3703
Website:		www.mwivet.com

Every effort has been made to ensure the accuracy of the Phenylpropanolamine 50 mg information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the Phenylpropanolamine 50 mg product label or package insert.